TrialCirculation2011

Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial.

Sharon Cresci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.